Skip to main content
main-content

Spondyloarthropathies

Axial spondyloarthritis

No worsening in disease activity with switch to biosimilar etanercept

Disease activity does not change following the switch from etanercept to the biosimilar formulation SB4, and treatment retention rates may be determined by patient-specific factors, suggests an analysis of the DANBIO registry.

15-11-2018 | Etanercept biosimilar | Highlight | News

No worsening in disease activity with switch to biosimilar etanercept

Disease activity does not change following the switch from etanercept to the biosimilar formulation SB4, and treatment retention rates may be determined by patient-specific factors, suggests an analysis of the DANBIO registry.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213474

21-10-2018 | Axial spondyloarthritis | ACR/ARHP 2018 | News

Online self-referral tool could help improve early SpA diagnosis

An online self-referral strategy for axial spondyloarthritis could raise awareness of the condition and improve early diagnosis, suggest findings from the OptiRef study.

Source:

ACR/ARHP Annual Meeting; Chicago, Illinois, USA: 19–24 October 2018

28-09-2018 | Axial spondyloarthritis | News

Ustekinumab disappoints in axSpA

Three phase III trials have failed to demonstrate efficacy of the IL-12/23 inhibitor ustekinumab in patients with axial spondyloarthritis.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40728

11-09-2018 | Spondyloarthropathies | News

Bone manifestations of PsA, nonradiographic axSpA characterized

Two studies published in Arthritis Research & Therapy describe the impact of psoriatic arthritis and nonradiographic axial spondyloarthritis on bone structure.

Source:

Arthritis Res Ther 2018; 20: 202, 203

21-08-2018 | Axial spondyloarthritis | Review | Article

Radiologic approach to axial spondyloarthritis: Where are we now and where are we heading?

Kucybała I, Urbanik A, Wojciechowski W. Rheumatol Int 2018. doi: 10.1007/s00296-018-4130-1

27-07-2018 | Axial spondyloarthritis | Article

Widespread pain in axial spondyloarthritis: Clinical importance and gender differences

Swinnen TW et al. Arthritis Res Ther 2018; 20: 156. doi: 10.1186/s13075-018-1626-8

Knowledge of features of inflammatory back pain in primary care in the West Midlands: A cross-sectional survey in the United Kingdom

The objective of this study was to assess current practice of our local general practitioners in using clinical features to assess patients with inflammatory back pain [read more].
Adizie T et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4058-5

17-07-2018 | Adalimumab biosimilar | News

approvalsWatch

EMA backs new adalimumab biosimilar

Click through for more information on this decision

21-06-2018 | Axial spondyloarthritis | Review | Article

Better quantification of syndesmophyte growth in axial spondyloarthritis

Ward MM, Tan S. Curr Rheumatol Rep 2018; 20: 46. doi: 10.1007/s11926-018-0759-8

21-06-2018 | Axial spondyloarthritis | Article

High reproducibility of an automated measurement of mobility for patients with axial spondyloarthritis

Garrido-Castro JL et al. J Rheumatol 2018. doi: 10.3899/jrheum.170941

07-06-2018 | Psoriatic arthritis | Article

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: Results from the FUTURE 2 study

McInnes IB et al. Arthritis Res Ther 2018; 20: 113. doi: 10.1186/s13075-018-1610-3

image credits